Literature DB >> 28802519

ESPEN guidelines on nutritional support for polymorbid internal medicine patients.

Filomena Gomes1, Philipp Schuetz2, Lisa Bounoure1, Peter Austin3, María Ballesteros-Pomar4, Tommy Cederholm5, Jane Fletcher6, Alessandro Laviano7, Kristina Norman8, Kalliopi-Anna Poulia9, Paula Ravasco10, Stephane M Schneider11, Zeno Stanga12, C Elizabeth Weekes13, Stephan C Bischoff14.   

Abstract

BACKGROUND & AIMS: Polymorbidity (also known as multimorbidity) - defined as the co-occurrence of at least two chronic health conditions - is highly prevalent, particularly in the hospitalized population. Nonetheless, clinical guidelines largely address individual diseases and rarely account for polymorbidity. The aim of this project was to develop guidelines on nutritional support for polymorbid patients hospitalized in medical wards.
METHODS: The methodology used for the development of the current project follows the standard operating procedures for ESPEN guidelines. It started with an initial meeting of the Working Group in January 2015, where twelve key clinical questions were developed that encompassed different aspects of nutritional support: indication, route of feeding, energy and protein requirements, micronutrient requirements, disease-specific nutrients, timing, monitoring and procedure of intervention. Systematic literature searches were conducted in three different databases (Medline, Embase and the Cochrane Library), as well as in secondary sources (e.g. published guidelines), until April 2016. Retrieved abstracts were screened to identify relevant studies that were used to develop recommendations, which were followed by submission to Delphi voting rounds.
RESULTS: From a total of 4532 retrieved abstracts, 38 relevant studies were analyzed and used to generate a guideline draft that proposed 22 recommendations and four statements. The results of the first online voting showed a strong consensus (agreement of >90%) in 68% of recommendations and 75% of statements, and consensus (agreement of >75-90%) in 32% of recommendations and 25% of statements. At the final consensus conference, a consensus greater than 89% was reached for all of the recommendations.
CONCLUSIONS: Despite the methodological difficulties in creating non-disease specific guidelines, the evidence behind several important aspects of nutritional support for polymorbid medical inpatients was reviewed and summarized into practical clinical recommendations. Use of these guidelines offer an evidence-based nutritional approach to the polymorbid medical inpatient and may improve their outcomes.
Copyright © 2017 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Guidelines; Hospitalized patients; Multimorbidity; Nutritional support; Polymorbidity

Mesh:

Year:  2017        PMID: 28802519     DOI: 10.1016/j.clnu.2017.06.025

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  53 in total

1.  Nutrition and Immunity in COVID-19.

Authors:  Marjan Moallemian Isfahani; Zahra Emam-Djomeh; Idupulapati M Rao; Nima Rezaei
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Characteristics of patients receiving nutrition care and its associations with prognosis in a tertiary hospital.

Authors:  María Teresa Pérez-Romero; José Luis Villanueva-Juárez; Aurora Elizabeth Serralde-Zúñiga; Lilia Castillo-Martínez
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-06-24       Impact factor: 1.712

Review 3.  Nutritional management of individuals with SARS-CoV-2 infection during rehabilitation.

Authors:  Amalia Tsagari; Grigoris Risvas; Jannis V Papathanasiou; Yannis Dionyssiotis
Journal:  J Frailty Sarcopenia Falls       Date:  2022-06-01

Review 4.  European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline.

Authors:  Stephan C Bischoff; Rocco Barazzoni; Luca Busetto; Marjo Campmans-Kuijpers; Vincenzo Cardinale; Irit Chermesh; Ahad Eshraghian; Haluk Tarik Kani; Wafaa Khannoussi; Laurence Lacaze; Miguel Léon-Sanz; Juan M Mendive; Michael W Müller; Johann Ockenga; Frank Tacke; Anders Thorell; Darija Vranesic Bender; Arved Weimann; Cristina Cuerda
Journal:  United European Gastroenterol J       Date:  2022-08-12       Impact factor: 6.866

5.  Comparing the Performance of Calf Circumference, Albumin, and BMI for Predicting Mortality in Immobile Patients.

Authors:  Xiao-Ming Zhang; Xinjuan Wu; Yunfen Ma; Chen Zhu; Jing Cao; Ge Liu; Fang-Fang Li; Andy S K Cheng
Journal:  Risk Manag Healthc Policy       Date:  2021-06-02

6.  COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology.

Authors:  M Puig-Domingo; M Marazuela; B O Yildiz; A Giustina
Journal:  Endocrine       Date:  2021-05-08       Impact factor: 3.633

7.  Energy and protein intake in medical and geriatric inpatients with MEDPass versus conventional administration of oral nutritional supplements: study protocol for the randomized controlled MEDPass Trial.

Authors:  Silvia Kurmann; Emilie Reber; Maria F Vasiloglou; Philipp Schuetz; Andreas W Schoenenberger; Katja Uhlmann; Anna-Barbara Sterchi; Zeno Stanga
Journal:  Trials       Date:  2021-03-16       Impact factor: 2.279

Review 8.  Optimizing Inpatient Nutrition Care of Adult Patients with Inflammatory Bowel Disease in the 21st Century.

Authors:  Elaine Chiu; Chris Oleynick; Maitreyi Raman; Barbara Bielawska
Journal:  Nutrients       Date:  2021-05-09       Impact factor: 5.717

9.  Impact of COVID-19 on nutritional status during the first wave of the pandemic.

Authors:  Analía Ramos; Clara Joaquin; Mireia Ros; Mariona Martin; Montserrat Cachero; María Sospedra; Eva Martínez; José Manuel Sánchez Migallón; María-José Sendrós; Berta Soldevila; Manel Puig-Domingo
Journal:  Clin Nutr       Date:  2021-05-08       Impact factor: 7.324

10.  Cost savings associated with nutritional support in medical inpatients: an economic model based on data from a systematic review of randomised trials.

Authors:  Philipp Schuetz; Suela Sulo; Stefan Walzer; Lutz Vollmer; Cory Brunton; Nina Kaegi-Braun; Zeno Stanga; Beat Mueller; Filomena Gomes
Journal:  BMJ Open       Date:  2021-07-09       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.